Skip to main content

Table 1 Patient age, symptoms, and other clinical measurements

From: Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area

Characteristic

Treatment arm

Number of patients

AP

(n = 110)

DHP

(n = 55)

AL

(n = 55)

P

value

Gender: Male/Female(ratio)

72/28(2.57)

43/12(3.58)

46/9(5.11)

NSa

Mean age, years(range)

25.2(7-55)

21.9(8-64)

27.4(7-58)

NS

Age Groups:

    

7-10

11(10.0%)

2(3.6%)

5(9.1%)

NS

11-15

16(14.54%)

5(9.1%)

5(9.1%)

NS

> 15

83(75.46%)

48(87.3%)

45(81.8%)

NS

mean duration of fever (in days) (range)

4.2 (1.3-7.1)

4.6 (1.3-7.9)

5.3 (1.1-9.5)

NS

Mean parasitaemia

(1 ×/μl)(range)

26637(3801-49473)

25850(195-51505)

31297(1215-61379)

NS

Body temperature (°C), mean (range)

38.5(37.7-39.3)

38.8 (37.7-39.9)

38.8(37.7-39.9)

NS

Hepatomegly rate (%)

5.5

14.5

7.3

NS

Splenomegly rate (%)

26.4

21.8

12.7

NS

  1. NS: Not significant, P > 0.05